Cargando…
Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis
Non-Small Cell Lung Cancer (NSCLC) is the most prevalent kind of lung cancer with around 85% of total lung cancer cases. Despite vast therapies being available, the survival rate is low (5 year survival rate is 15%) making it essential to comprehend the mechanism for NSCLC cell survival and progress...
Autores principales: | Gulhane, Pooja, Singh, Shailza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133877/ https://www.ncbi.nlm.nih.gov/pubmed/37062237 http://dx.doi.org/10.1016/j.tranon.2023.101673 |
Ejemplares similares
-
Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
por: Samarth, Nikhil, et al.
Publicado: (2022) -
Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach
por: Gulhane, Pooja, et al.
Publicado: (2022) -
Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer
por: Baietti, Maria Francesca, et al.
Publicado: (2023) -
Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
por: Mumtaz, Ibtisam, et al.
Publicado: (2022) -
Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
por: Ryan, Brent J., et al.
Publicado: (2014)